Details
Renal Pharmacotherapy
Dosage Adjustment of Medications Eliminated by the Kidneys2nd ed. 2021
|
74,89 € |
|
| Verlag: | Springer |
| Format: | |
| Veröffentl.: | 24.09.2021 |
| ISBN/EAN: | 9783030586508 |
| Sprache: | englisch |
Dieses eBook enthält ein Wasserzeichen.
Beschreibungen
<div><div><br></div><div>To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications.</div><div><br></div><div>This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types.</div><div><br></div><div>Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.</div><div><br></div><div><br></div></div><div><br><p></p></div>
<p>A: Acamprosate to Aztreonam.- B: Bacitracin to Butorphanol.- : Capecitabine to Cycloserine.- D: Dabigatran to Dyphylline.- E: Edetate Calcium Disodium to Exenatide.- F: Famciclovir to Fosfomycin.- H: Hetastarch to Hydroxyurea.- I: Ibandronate to Itraconazole.- K: Kanamycin to Ketorolac.- L: Lacosamide to Lurasidone.- M: Magnesium Citrate to Mycophenolate Mofetil.- N: Nabumetone to Norfloxacin.- O: Ofloxacin to Oxcarbazepine.- P: Paliperidone to Pyridostigmine.- Q: Quinapril to Quinine.- R: Ramipril to Ruxolitinib.- S: Salsalate to Sunitinib.- T: Tadalafil to Trospium.- V: Valacyclovir to Voriconazole.- Z: Zalcitabine to Zonisamide.- Proprietary Name Index.</p><p></p>
<p>Larry K. Golightly, PharmD</p>
<p>Clinical Research Pharmacist</p>
<p>University of Colorado Hospital</p>
Aurora, CO 80045<p></p>
<p>larry.golightly@uchealth.org</p>
<p> </p>
Isaac Teitelbaum, MD, FACP<p></p>
<p>Professor of Medicine</p>
<p>Renal Medicine and Hypertension Section, Division of General Internal Medicine</p>
<p>University of Colorado School of Medicine and</p>
<p>Director, Home Dialysis Program</p>
<p>University of Colorado Hospital</p>
<p>Aurora, CO 80045</p>
<p>isaac.teitelbaum@cuanschutz.edu</p>
<p> </p>
<p>Bonita A. Simendinger, PharmD, BCPS</p>
<p>P&T Formulary Compliance Specialist</p>
<p>University of Colorado Hospital</p>
<p>Aurora, CO 80045</p>
<p>bonita.simendinger@uchealth.org</p>
<p> </p>
<p>Tyree H. Kiser, PharmD, BCPS, FCCP, FCCM</p>
<p>Professor, Department of Clinical Pharmacy</p>
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and<p></p>
<p>Critical Care Pharmacy Specialist</p>
<p>University of Colorado Hospital</p>
<p>Aurora, CO 80045</p>
<p>ty.kiser@cuanschutz.edu</p>
<p> </p>
<p>Gerard R. Barber, RPh, MPH, FASHP</p>
<p>Clinical Assistant Professor, Department of Clinical Pharmacy</p>
<p>University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences</p>
<p>Aurora, CO 80045</p>
<p>gerard.barber@cuanschutz.edu</p>
<p> </p>
<p>Nancy M. Stolpman, PharmD, PhD</p>
<p>Associate Clinical Professor</p>
<p>University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and</p>
<p>Lead Director of Pharmacy</p>
<p>UCHealth</p>
<p>Aurora, CO 80045</p>
nancy.stolpman@uchealth.org<p></p><br><p></p>
<p>Clinical Research Pharmacist</p>
<p>University of Colorado Hospital</p>
Aurora, CO 80045<p></p>
<p>larry.golightly@uchealth.org</p>
<p> </p>
Isaac Teitelbaum, MD, FACP<p></p>
<p>Professor of Medicine</p>
<p>Renal Medicine and Hypertension Section, Division of General Internal Medicine</p>
<p>University of Colorado School of Medicine and</p>
<p>Director, Home Dialysis Program</p>
<p>University of Colorado Hospital</p>
<p>Aurora, CO 80045</p>
<p>isaac.teitelbaum@cuanschutz.edu</p>
<p> </p>
<p>Bonita A. Simendinger, PharmD, BCPS</p>
<p>P&T Formulary Compliance Specialist</p>
<p>University of Colorado Hospital</p>
<p>Aurora, CO 80045</p>
<p>bonita.simendinger@uchealth.org</p>
<p> </p>
<p>Tyree H. Kiser, PharmD, BCPS, FCCP, FCCM</p>
<p>Professor, Department of Clinical Pharmacy</p>
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and<p></p>
<p>Critical Care Pharmacy Specialist</p>
<p>University of Colorado Hospital</p>
<p>Aurora, CO 80045</p>
<p>ty.kiser@cuanschutz.edu</p>
<p> </p>
<p>Gerard R. Barber, RPh, MPH, FASHP</p>
<p>Clinical Assistant Professor, Department of Clinical Pharmacy</p>
<p>University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences</p>
<p>Aurora, CO 80045</p>
<p>gerard.barber@cuanschutz.edu</p>
<p> </p>
<p>Nancy M. Stolpman, PharmD, PhD</p>
<p>Associate Clinical Professor</p>
<p>University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and</p>
<p>Lead Director of Pharmacy</p>
<p>UCHealth</p>
<p>Aurora, CO 80045</p>
nancy.stolpman@uchealth.org<p></p><br><p></p>
<p><br></p><p>To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications.</p><p><br></p><p>This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types.</p><p><br></p><p>Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.</p><p><br></p><p><br></p><p></p>
Renal Pharmacotherapy is a comprehensive and evidence-based listing of dosage recommendations for patients with compromised renal function This updated edition closes several identified knowledge gaps concerning medications eliminated by the kidneys Nephrologists and a broad range of health professionals will be interested in this reference
Diese Produkte könnten Sie auch interessieren:
Razum prestupnika i logika prestupleniya. O psihiatrii, sudah i seriynyh ubiytsah
von: Shohom Das, Dmitry Chepusov
6,99 €
Samoe glavnoe o zhenskom zdorove. Voprosy nizhe poyasa
von: Elizaveta Grebeshkova, Olga Sedova
9,99 €
